- Type :Webinar
- Date :May 12, 4:00 pm - 5:00 pm, 2015
- Tags :Healthcare
China’s medical technology market is expected to become the second largest in the world in the next five to seven years. China represents numerous opportunities for European companies but understanding the practicalities of accessing the market is not simple.
In this context, the EU SME Centre and the China-Britain Business Council (CBBC) will host a joint webinar to update you on the latest changes in China’s medical devices regulations and a wider picture of Health China 2020. It will explain the changes in the product registration process, clinical trials for advanced medical devices and alternative solutions for class I and/or II devices to access the market.
This webinar will also serve as a pre-departure briefing for companies that plan to attend this year’s China Medical Equipment Fair (CMEF) in Shanghai in May, the largest exhibition of medical technology in the Asia-Pacific region.
In this webinar, you will learn:
- The current Chinese healthcare reform and hospital provision system;
- The regulatory structure of China’s medical devices market;
- The latest changes by China Food and Drug Administration (CFDA) in the product registration process, procedure of clinical trials, and potential impact on SMEs;
- Possible alternative solutions for class I and/or II devices to access the market;
- Opportunities and challenges for EU SMEs in R&D collaboration and wearable devices market for a mega-health initiative in China.
About the Speaker
Anna Zhao, Sector Lead, Healthcare & Life Sciences, CBBC
Anna has 20 years’ work experience in both the Chinese and UK healthcare system. Before joining the China-Britain Business Council, she worked for the British Embassy in Beijing, leading the healthcare and life sciences sector, with a focus on Medical Technology China-wide to help UK businesses succeed in the challenging Chinese market. She worked with both well-established large corporates and SMEs new to the Chinese market.
Before moving into business, Anna used to be an anaesthetist and spent 10 years in medical practice in Peking Union Medical College (PUMC) Hospital, NHS Derriford Hospital in the UK, China-Japan Friendship Hospital. During the SARS outbreak, Anna worked in ICU and the World Health Organisation (WHO) China office. She holds a MBA in International Hospital Management from Europe.
Chao Xu, PhD., Managing Director of Europe Branch, Osmunda Medical Device Service Group
Chao joined OSMUNDA in 2011 as a consultant for regulatory affairs in the Europe CE-marking and China CFDA approval. In 2013, she was appointed as the Managing Director of Europe Branch responsible for international business and collaborations.
Chao earned her master and PhD degree in the Charité, Berlin Medical University. During this period, she worked as a research scientist in the Max-Planck Institute, Leipzig and directed clinical trial in close collaboration with the Siemens Diagnostic Imaging Division. She also graduated from Shanghai Jiaotong University with a bachelor degree in Biomedical Engineering.
She speaks fluent English, German and Chinese.
Peipei Xiong, Project Executive, Research Team, Healthcare & Life Sciences, CBBC
The contents of this webinar have been prepared for general informational purposes only and are not intended to be relied upon as legal or other professional advice. The opinions of the experts, whether the speaker or the moderator, orally or written during the webinar, do NOT constitute or represent that of the EU SME Centre on the subject matter. The EU SME Centre accepts no liability for any errors, omissions or misleading statements, and no warranty is given or responsibility accepted as to the standing of any individual, company or other organization mentioned. Consultation and confirmation are strongly suggested to be made with relevant government authorities or independent service providers before any action is taken.
Please login to access the recorded video and the slide.